Skip to main content

and
  1. No Access

    Article

    Dual stress factors adaptive evolution for high EPA production in Schizochytrium sp. and metabolomics mechanism analysis

    Eicosapentaenoic acid (EPA) is a vital ɷ-3 polyunsaturated fatty acid (PUFA) for human body with various physiological functions. In this study, we proposed an adaptive evolutionary strategy based on high-temp...

    Ying Ou, Yu Qin, Shoushuai Feng, Hailin Yang in Bioprocess and Biosystems Engineering (2024)

  2. Article

    Open Access

    Transitory restless arms syndrome in a patient with antipsychotics and antidepressants: a case report

    Restless arms syndrome (RAS) is characterized by uncomfortable aching or burning sensations in the arms. RAS is regarded as an upper limb variant of restless legs syndrome (RLS). The lack of specific diagnosti...

    Juan Chen, Na Meng, Bingrong Cao, Yinghua Ye, Ying Ou, Zhe Li in BMC Psychiatry (2021)

  3. Article

    Open Access

    Effect of rifampin and itraconazole on the pharmacokinetics of zanubrutinib (a Bruton's tyrosine kinase inhibitor) in Asian and non-Asian healthy subjects

    Zanubrutinib (BGB-3111) is a potent Bruton’s tyrosine kinase inhibitor with promising clinical activity in B-cell malignancies. Zanubrutinib was shown to be mainly metabolized through cytochrome P450 3A (CYP3A...

    Song Mu, Zhiyu Tang, William Novotny, Manal Tawashi in Cancer Chemotherapy and Pharmacology (2020)

  4. No Access

    Article

    The influence of undetermined deaths on suicides in Shanghai, China

    In global forensic practice, some suicides were misclassified as undetermined deaths, leading to suicide underreporting. In this study, we aimed to explore the influence of undetermined deaths on suicides in S...

    Feng Li, Xuesong Lu, Ying Ou, Paul S. F. Yip in Social Psychiatry and Psychiatric Epidemio… (2019)

  5. Article

    Open Access

    Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study

    Carfilzomib is approved in the United States and Europe for treatment of relapsed or refractory multiple myeloma (MM). This study evaluated pharmacokinetics (PK) and safety of carfilzomib in patients with rela...

    Jennifer Brown, Ruth Plummer, Todd M. Bauer in Experimental Hematology & Oncology (2017)

  6. Article

    Open Access

    Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

    The pharmacokinetics (PK) of carfilzomib have been previously studied in multiple myeloma patients with varying degrees of renal impairment (normal, mild, moderate, severe, and end-stage renal disease [ESRD]) ...

    Hang Quach, Darrell White, Andrew Spencer in Cancer Chemotherapy and Pharmacology (2017)

  7. No Access

    Article

    Identification of allelic expression imbalance genes in human hepatocellular carcinoma through massively parallel DNA and RNA sequencing

    Hepatocellular carcinoma (HCC) is a common malignant tumor worldwide. The prognosis and treatment of this disease have changed little in recent decades because the mechanisms underlying most events of this dis...

    Qiudao Wang, Yan An, Qing Yuan, Yao Qi, Ying Ou, Junhui Chen in Medical Oncology (2016)

  8. Article

    Open Access

    Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMESin human hepatocellular carcinoma

    Differences in 5-hydroxymethylcytosine, 5hmC, distributions may complicate previous observations of abnormal cytosine methylation statuses that are used for the identification of new tumor suppressor gene cand...

    Fei Gao, Yudong **a, Junwen Wang, Zhilong Lin, Ying Ou, in Genome Biology (2014)

  9. No Access

    Article

    Albubnp, a Recombinant B-type Natriuretic Peptide and Human Serum Albumin Fusion Hormone, as a Long-Term Therapy of Congestive Heart Failure

    Purpose. B-type natriuretic peptide (BNP) has been in clinical use for the treatment of decompensated congestive heart failure. However, BNP has a very short half-life in circulation, which limits its applicatio...

    Wei Wang, Ying Ou, Yanggu Shi in Pharmaceutical Research (2004)